Back to All Speakers

Tony P. George, MD, FRCPC

Addictions Division at CAMH, and Professor of Psychiatry, University of Toronto

When the majority of a population engage in a particular behavior, it is telling us something about the commonalities between the two disorders. It is also a window into how to better treat those co-occurring disorders.

Learn the biopsychological determinants of tobacco use in patients with serious mental illness and their evidence-based treatments.

Dr. George is one of the first clinical scientists to study the biology and treatment of co-morbid tobacco use disorder in patients with serious mental illness. Examining this link has lead to important conclusions, as well as contributions to the field of tobacco dependence treatment. These include:

  • Acting as the principal investigator for grants totalling over $25 million from the NIH and the Canadian Institutes of Health Research (CIHR) since 1999.
  • Publishing over 220 peer-reviewed publications in the area of cognitive neuroscience and addictions co-morbidity in patients with mental illness.
  • Author of the Nicotine and Tobacco chapter in the Cecil Textbook of Medicine (24th edition, 2011 and 25th edition, 2015).

His research has given him a better understanding of how mental illness and tobacco dependence relate to each other, and the treatments that are most effective for these patients.

Professional highlights

Professor of Psychiatry, University of Toronto

Chief, Addictions Division, Centre for Addiction and Mental Health (CAMH)

Deputy Editor, Neuropsychopharmacology journal

Member, Addiction Risks and Mechanisms Study Section

Center For Scientific Review

Inaugural chair holder in Addiction Psychiatry, University of Toronto

Associate Professor of Psychiatry, Yale University

Neuropharmacology fellowship, Yale University School of Medicine

Previous Sessions

Monday, May 22, 2017

Co-occurring Tobacco Dependence and Mental Illness

Monday, May 22, 2017

Update on Pharmacotherapy